Juul, The Ecig Maker Started At Stanford, Watches Its U.S. Market Share Get Vaporized
It's almost Shakespeare.
Jules, an e-cigarette maker who made $38 billion in the US five years ago, is about to be deported, according to the WSJ. Starting today, the Food and Drug Administration may announce that San Francisco clothing companies are prohibited from selling their products in the United States, Publika.az writes.
The WSJ writes that the "Marketing Opt Out Order" states that almost two years after reviewing the information provided by Jool, all print, television and digital advertising in the United States will be closed in 2019 based on complaints from parents in the country. Their children became addicted to and addicted to jute products.
The company also agreed to stop selling sweet-smelling liquids in e-containers, including fruit, cream, mango and cucumber flavors.
Since then, Jules, who sold a 35% stake in Altria's tobacco business for $0.812.8 billion in 2018, has lobbied the federal government for millions of dollars in hopes of continuing to sell menthol. Perfumes in the US market.
Last summer, according to the New York Times, Jules filed a 125,000-page petition with the agency; The settlement of the lawsuit cost $40 million. $51,000 for the May/June 2021 issue of the American-funded American Journal of Health Behavior.
Bull, who has faced thousands of lawsuits, agreed in April to pay $22.5 million to the state of Washington for intentionally targeting the cases before filing a lawsuit in federal district court under the supervision of a federal judge. User confidence in products.
As noted at the time, under the terms of the agreement, Jules admitted no wrongdoing or liability, saying he agreed to a "compromise" to avoid further lawsuits (a lawsuit that could hinder progress with the FDA). )
The story goes on
By all appearances, all of these efforts have been minimal, although the FDA has cleared Zulu's biggest competitor, Reynolds American և NJOY Holdings, to continue selling its e-cigarettes on the market.
Assuming its days in the US are over, this chapter will be an incredible journey for the now seven-year-old company that has easily conquered 75% of the US e-cigarette market in its third year. Mainly thanks to the elegant design of the nicotine vaporizer.
In fact, he is said to be backed by big investors, including Tiger Global և Fidelity Investments, which plans to spend at least $1 billion internationally in 2018 to attract nearly a billion smokers living abroad. : United States:
https://platform.twitter.com/widgets.js:
The FDA, led by then-physician venture capital commissioner Scott Gottlieb, was accused of thwarting these plans. In Gottlieb's time, the FDA spoke poignantly of the yearly use of e-cigarette pens by high school students, as well as the younger but more attractive percentage of school-age children who started smoking.
Bull initially denied the allegations. In the fall of 2018, at this publisher event, co-founded by Jule, former Stanford University design student James Bowen. James Monsis was the only public figure still in favor of pitcher-flavored cigarettes. . "The capsules make it easier for smokers to switch products, reducing harm," he said.
Monsieur suggested that tastes were "clearly on the table" at the time. However, he continued. “We haven't seen any evidence that taste is the full reason for underage consumers. Cigarettes have long been a major problem for underage users. The stronger the proof we see inside, the stronger the connection when the taste fades.
It took 13 months of July to stop selling this perfume.
Monsieur և Bowen first presented at Stanford in 2004 a dissertation on product design on the topic "the future of smoking". Three years later, in 2007, the alumni founded a company called Plum, which produces cannabis vaporizers. Plum introduced the product to a company investor (Japan Tobacco International) and Jules focused on e-cigarettes. In 2017, Jules Labs left his company.
Bull initially talked about the health benefits of switching from open to e-cigarettes, but doctors and researchers say that while the fumes are less harmful than smoking, they are still addictive; There are many unknowns.
For example, evidence suggests a link between chronic lung disease, asthma, as well as e-cigarette doping, smoking and cardiovascular disease, says Michael Blahan, MD, MPhD, director of clinical research at Johns Hopkins University. Cicaron Center.. Prevention of heart disease in the online message of the medical center.
The WSJ notes that if the FDA orders Jules to withdraw its products from the US market, the company still has a few options. He can "appeal to the FDA, challenge the decision in court, or file an appeal to review his products."
At the same time, it is not known at the moment what he will do after leaving office. In 2019, a few days after the nationwide sale, jute sales in China ended.
As reported by BuzzFeed News, Juul plans to significantly reduce its presence in Europe during the epidemic, stopping sales in Austria, Belgium, Portugal, France and Spain. Europe, as noted by BuzzFeed at the time, has stricter e-cigarette regulations than the United States, including tighter restrictions on nicotine.
[youtube https://www.youtube.com/watch?v=pi-yzqKpSIk?version=3&rel=1&showsearch=0&showinfo=1&iv_load_policy=1&fs=1&hl=en-US&autohide=2&wmode=transparent&w=60]
Komentar
Posting Komentar